Answers are grounded in this paper and cite their sources.
A novel 980 nm laser-driven hydrophobic anticancer drug-delivery platform based on hollow CuS nanoparticles is constructed in this work. The excellent synergistic therapy combining drug treatment and photothermal ablation of cancer cells both in vitro and in vivo is demonstrated, which opens up new opportunities for biological and medical applications.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: